Previous Article |
Table of Contents
| Next Article
* Edward A. Doisy Department of Biochemistry and Molecular Biology
and Contributed by William S. Sly, December 28, 2000
Mucopolysaccharidosis type VII (MPS VII; Sly syndrome) is an
autosomal recessive lysosomal storage disorder due to an inherited deficiency of
Applied Biological Sciences
Active site mutant transgene confers tolerance to human
-glucuronidase without affecting the phenotype of MPS VII mice
,
,
Department of Pathology, Saint Louis University
School of Medicine, St. Louis, MO 63104
-glucuronidase. A naturally occurring mouse model for
this disease was discovered at The Jackson Laboratory and shown to be
due to homozygosity for a 1-bp deletion in exon 10 of the
gus gene. The murine model MPS VII
(gusmps/mps) has been very well
characterized and used extensively to evaluate experimental strategies
for lysosomal storage diseases, including bone marrow transplantation,
enzyme replacement therapy, and gene therapy. To enhance the value of
this model for enzyme and gene therapy, we produced a transgenic mouse
expressing the human
-glucuronidase cDNA with an amino acid
substitution at the active site nucleophile (E540A) and bred it onto
the MPS VII (gusmps/mps) background. We
demonstrate here that the mutant mice bearing the active site mutant
human transgene retain the clinical, morphological, biochemical, and
histopathological characteristics of the original MPS VII
(gusmps/mps) mouse. However, they are now
tolerant to immune challenge with human
-glucuronidase. This
"tolerant MPS VII mouse model" should be useful for preclinical
trials evaluating the effectiveness of enzyme and/or gene therapy
with the human gene products likely to be administered to human
patients with MPS VII.
To whom correspondence should be addressed at: Edward
A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, 1402 South Grand Boulevard, St. Louis,
MO 63104. E-mail: slyws{at}slu.edu.
www.pnas.org/cgi/doi/10.1073/pnas.051623698
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
Y. Kimura, M. Saito, Y. Kimata, and K. Kohno Transgenic Mice Expressing a Fully Nontoxic Diphtheria Toxin Mutant, not CRM197 Mutant, Acquire Immune Tolerance against Diphtheria Toxin J. Biochem., July 1, 2007; 142(1): 105 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Sly, C. Vogler, J. H. Grubb, B. Levy, N. Galvin, Y. Tan, T. Nishioka, and S. Tomatsu Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors PNAS, October 10, 2006; 103(41): 15172 - 15177. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tomatsu, M. Gutierrez, T. Nishioka, M. Yamada, M. Yamada, Y. Tosaka, J. H. Grubb, A. M. Montano, M. B. Vieira, G. G. Trandafirescu, et al. Development of MPS IVA mouse (Galnstm(hC79S{middle dot}mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase Hum. Mol. Genet., November 15, 2005; 14(22): 3321 - 3335. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vogler, B. Levy, J. H. Grubb, N. Galvin, Y. Tan, E. Kakkis, N. Pavloff, and W. S. Sly From The Cover: Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII PNAS, October 11, 2005; 102(41): 14777 - 14782. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. LeBowitz, J. H. Grubb, J. A. Maga, D. H. Schmiel, C. Vogler, and W. S. Sly Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice PNAS, March 2, 2004; 101(9): 3083 - 3088. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tomatsu, K. O. Orii, C. Vogler, J. H. Grubb, E. M. Snella, M. Gutierrez, T. Dieter, C. C. Holden, K. Sukegawa, T. Orii, et al. Production of MPS VII mouse (Gustm(hE540A{middle dot}mE536A)Sly) doubly tolerant to human and mouse {beta}-glucuronidase Hum. Mol. Genet., May 1, 2003; 12(9): 961 - 973. [Abstract] [Full Text] [PDF] |
||||